Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
27 studies found for:    " October 31, 2012":" November 30, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 31, 2012":" November 30, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed An Evaluation of a Rapid Test for HIV
Condition: HIV Seropositivity
Intervention: Device: Rapid testing for HIV
2 Active, not recruiting Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: EVG/COBI/FTC/TDF
3 Terminated A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid;   Drug: tenofovir DF 300 mg qd
4 Withdrawn A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid
5 Withdrawn A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients
Condition: Human Immunodeficiency Virus-Type 1
Intervention: Drug: No intervention
6 Recruiting Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection
Condition: Human Immunodeficiency Virus
Interventions: Drug: Busulfan;   Biological: Cal-1 modified HSPC;   Biological: Cal-1 modified CD4+ T lymphocytes
7 Completed Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine
Condition: HIV
Interventions: Drug: Etravirine;   Drug: Darunavir/ritonavir;   Drug: artemether/lumefantrine
8 Recruiting Secondary HIV Prevention and Adherence Among HIV-infected Drug Users
Conditions: Risk Behavior;   Medication Adherence;   HIV
Interventions: Behavioral: 3H+ (Holistic Health for HIV);   Behavioral: HHRP+ (Holistic Health Recovery Program)
9 Completed Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
Conditions: Cocaine-Related Disorders;   HIV;   Heroin Dependence
Interventions: Drug: Methadone;   Drug: Buprenorphine;   Behavioral: Employment-based drug abstinence reinforcement
10 Recruiting Doxycycline for COPD in HIV-Infected Patients
Conditions: HIV;   Chronic Obstructive Pulmonary Disease (COPD);   Emphysema
Intervention: Drug: Doxycycline
11 Completed
Has Results
Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users
Conditions: HIV;   Opioid Dependence
Interventions: Behavioral: Community-friendly Health Recovery Program;   Behavioral: Time-and-Attention-Matched Control Condition
12 Unknown  A Pilot Trial of an Individualized Web-Based Condom Use Intervention
Condition: HIV
Intervention: Behavioral: Condom-HIM
13 Recruiting A Prospective, Observational Study to Examine the Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'
Conditions: HIV Positive;   Ageing
Intervention:
14 Recruiting Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
Conditions: HIV Infection;   Alcohol Use;   Bone Disease;   Substance-Related Disorders
Intervention:
15 Recruiting Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women
Condition: HIV
Intervention: Drug: maraviroc
16 Active, not recruiting Black Men Evolving Behavioral HIV Prevention Intervention for Black MSM
Condition: HIV CDC Category A1
Intervention: Behavioral: B-ME Intervention
17 Not yet recruiting Neurocognitive Effects of Opiate Agonist Treatment
Conditions: Opioid-Related Disorders;   HIV;   HIV Infections
Interventions: Drug: Buprenorphine;   Drug: Methadone
18 Completed DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate
Condition: HIV
Interventions: Drug: dapivirine;   Drug: miconazole
19 Unknown  A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.
Condition: HIV
Intervention: Drug: Darunavir, Ritonavir and Rilpivirine
20 Terminated Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease
Condition: HIV Disease
Intervention: Biological: α1 Proteinase Inhibitor

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years